Anton A. Toutov, Ph.D., is the Co-Founder and Chief Science Officer of Los Angeles-based start-up, Fuzionaire, which spun out of Caltech in 2016. His work involves developing alternatives to precious metal catalysts for known and novel organic reactions, such as employing sodium and potassium salts to catalyze a variety of cross-coupling chemistries. Dr. Toutov holds a B.S. in chemistry from Queen's University and a Ph.D. in organic chemistry from Caltech, working in the laboratory of Prof. Robert H. Grubbs, where he held Dow–Resnick, NSERC, and Bristol–Myers Squibb fellowships.
Raymond N. Dominey, Ph.D., is an Adjunct Associate Professor in the Department of chemical and life science engineering. He studied chemistry at the University of West Florida (B.S.), MIT (Ph.D. Advisor: Mark S. Wrighton), and UNC-Chapel Hill (Post-Doc Advisor: David Whitten). He is an associate professor of chemistry at the University of Richmond where he works with undergraduate students on research projects focused in two main areas: 1) the interface of physical, analytical, and synthetic chemistry, particularly as it applies to developing flow chemistry methods for synthesis of important APIs, and 2) energy research, in particular CO2 reduction. His work at Medicines for All focuses on developing Electrosonic Spray Ionization (ESSI) as a flow chemistry method for accelerating organic reactions and using NMR to elucidate synthesis pathways for optimizing flow syntheses of APIs, e.g. fluconazole.